Elizabeth Asztalos

Research Synopsis

Dr. Asztalos' primary area is in clinical epidemiology, with the body of her work in clinical trials. Her main areas of strength are the neurodevelopmental monitoring and follow-up of high-risk infants. She was the principal investigator for the five-year follow-up study of children whose mothers participated in the Multiple Courses of Antenatal Corticosteroids (MAC-5) study, which was recently completed in 2012. She also just concluded a clinical trial on the safety and effectiveness of domperidone in breast milk production, the EMPOWER study. She is also the principal investigator for LIFT_Canada, a Canadian multi-centre RCT which will evaluate whether bovine lactoferrin will improve survival of very low birth weight infants without significant morbidities.